[Pathomorphological changes in albino mice infected with plague and treated with cefotaxime]

Insights

Cefotaxime effectively treated plague in mice, preventing generalized infection and allowing survival. Histological and bacteriological studies confirmed localized infection and pathogen elimination.

Area of Science:

  • Microbiology
  • Pathology
  • Pharmacology

Context:

  • Plague, a severe zoonotic disease, poses a significant public health threat.
  • Investigating effective antimicrobial treatments for plague is crucial for disease control.
  • Understanding the pathomorphological and bacteriological progression of plague is essential.

Purpose:

  • To investigate the efficacy of cefotaxime in treating experimental plague in albino mice.
  • To evaluate the pathomorphological and bacteriological changes in mice infected with plague and treated with cefotaxime.

Summary:

  • Control mice infected with plague exhibited generalized disease with widespread organ lesions and detectable Yersinia pestis in tissues and blood.
  • Cefotaxime treatment (200 mg/kg for 7 days) resulted in survival of all mice.
  • Histological examination revealed that cefotaxime restricted the infection to the primary site, preventing systemic spread and characteristic plague lesions. Productive inflammation, organization, and cicatrization were observed.
  • Bacteriological analysis confirmed the presence of Yersinia pestis in the infection site during early treatment but its subsequent absence, indicating successful eradication.

Impact:

  • Cefotaxime demonstrates significant therapeutic potential for treating plague, as evidenced by survival and localized infection.
  • This study provides valuable insights into the treatment mechanisms and pathological outcomes of cefotaxime in plague management.
  • Findings support the use of cefotaxime as a viable option in plague treatment strategies.